INTRAVENOUS NUTRIENT SOLUTIONS
Sayed nour
Parenteral nutrition is the continuous
infusion of a hyperosmolar solution containing carbohydrates, proteins, fat, and other necessary nutrients through an intravenous route Parenteral nutrition is used when the enteral route is unable to provide or sustain sufficient caloric intake.
Goals of Nutrition Support
To minimize protein breakdown, To preserve lean body mass, To promote protein synthesis,
and To optimize immune responses
PN Summary Guidelines
1. Determine if PN is truly indicated 2. Assess the patient (medical history, medication profile, anthropometric data & lab values) 3. Determine need for long-term vs. short term
<710 days
4. Confirm or establish adequate IV access
Peripheral or central?
5. Determine estimated kcal, protein and lipid needs
2030 kcal/kg Protein 0.81.5 gm/kg Higher levels may be needed in severe catabolic states Lipid to provide 30% of kcals
6. Determine initial electrolyte, vitamin and trace element requirements; consider ongoing losses 7. Consider any additional additives to PN formulation including insulin and H2-receptor antagonists
8. Monitor for:
Risk of refeeding syndrome Glucose intolerance Start low & advance slowly if labs stable over 24-48 hours Fluid, electrolyte, metabolic, macro- and micro-nutrient changes Complications sepsis, thrombosis, abuse
9. Initiate trophic feedings or convert patient to PO or enteral feeding when feasible
Dextrose Solutions
the standard nutritional support regimen uses
carbohydrates to supply approximately 70% of the daily (nonprotein) calorie requirements. These are provided by dextrose (glucose) solutions, which are available in various strengths. As dextrose is not a potent metabolic fuel, the solutions must be concentrated to provide enough calories to satisfy daily requirements. As a result, the dextrose solutions used for TPN are hyperosmolar and should be infused through large central veins
Intravenous Dextrose Solutions
Amino acid solutions
Amino acid solutions are mixed together with
the dextrose solutions to provide the daily protein requirements. A variety of amino acid solutions are available for specific clinical settings. The standard amino acid solutions contain approximately 50% essential amino acids and 50% nonessential + semiessential amino acids
Amino acid cont
The nitrogen in essential amino acids is
partially recycled for the production of nonessential amino acids So metabolism of essential amino acids produces less of a rise in the blood urea nitrogen concentration than metabolism of nonessential amino acids amino acid solutions designed for use in renal failure are rich in essential amino acids
Standard and Specialty Amino Acid Solutions
Glutamine
Glutamine is the principle metabolic fuel for
intestinal epithelial cells, Glutamine-supplemented TPN has an important role in maintaining the functional integrity of the bowel mucosa and preventing bacterial translocation. Glutamine is formed when glutamic acid combines with ammonia in the presence of the enzyme glutamine synthetase. Glutamic acid is given as exogenous source of glutamine.
Amino Acid Solutions with Glutamic Acid
Lipid Emulsions
Intravenous lipid emulsions consist of
submicron droplets (=0.45 mm) of cholesterol and phospholipids surrounding a core of longchain triglycerides The triglycerides are derived from vegetable oils (safflower or soybean oils) and are rich in linoleic acid, an essential polyunsaturated fatty acid lipid emulsions are available in 10% and 20% strengths (the percentage refers to grams of triglyceride per 100 mL of solution). The 10% emulsionsprovide approximately 1 kcal/mL, and the 20% emulsions provide 2 kcal/mL
Unlike the hypertonic dextrose solutions, lipid
emulsions are roughly isotonic to plasma Can be infused through peripheral veins. The lipid emulsions are available in unit volumes of 50 to 500 mL They can be infused separately (at a maximum rate of 50 mL/hour) or added to the dextroseamino acid mixtures. The triglycerides introduced into the bloodstream are not cleared for 8 to 10 hours, and lipid infusions often produce a transient, lipemic-appearing (whitish) plasma.
Intravenous Lipid Emulsions
Lipid Restriction
Lipids are used to provide up to 30% of the
daily (nonprotein) calorie requirements. Dietary lipids are oxidation-prone and can promote oxidant-induced cell injury Use of lipids in critically ill patients (who often have high oxidation rates) should be restricted. Minimal amounts (4% of calorie) of lipid infusion is necessary to prevent essential fatty acid deficiency (cardiomyopathy, skeletal muscle myopathy)
Additives
Electrolytes
Most electrolyte mixtures contain sodium,
chloride, potassium, and magnesium; they also may contain calcium and phosphorous. The daily requirement for specific electrolyte can be specified in the TPN orders. If no electrolyte requirements are specified, the electrolytes are added to replace normal daily electrolyte losses.
Normal Serum Electrolytes
Parenteral & Enteral Intake Ranges
Vitamins
Aqueous multivitamin preparations are added to the
dextroseamino acid mixtures. One unit vial of a standard multivitamin preparation will provide the normal daily requirements for most vitamins Enhanced vitamin requirements in hypermetabolic patients in the ICU may not be satisfied. Some vitamins are degraded before they are delivered. Some examples are riboflavin and pyridoxine (which are degraded by light) and thiamine (which is degraded by sulfites used as preservatives for amino acid solutions)
Vitamins
Vitamin Thiamine (B1) Riboflavin (B2) Pyridoxine (B6) Cyanocobalamin (B12) Niacin Folic acid Pantothenic acid Biotin Ascorbic acid (C) Vitamin A Vitamin D Vitamin E Vitamin K RDI (FDA/AMA/NAG) 6 mg 3.6 mg 6 mg 5 mcg 40 mg 600 mcg 15 mg 60 mcg 200 mg 3300 IU 5 mg 10 IU 150 mcg
Trace Elements
A variety of trace element additives are available Most trace element mixtures contain chromium,
copper, manganese, and zinc, but they do not contain iron and iodine. Some mixtures contain selenium, which has a role in proctection against oxidation injury Routine administration of iron is not recommended in critically ill patients because of the pro-oxidant actions of iron
Trace Element Preparations and Daily Requirements
Monitoring PN Patients Clinical Status
Vital signs Intake/output
Urine, Stool, Other (eg fistula output)
Weight Fluid requirements Patient complaints Physical exam Overall clinical status
Monitoring PN Patients Metabolic and Biochemical Aspe
Blood studies
Renal function: Lytes, Mg, Ca, Phos, BUN, Cr Hematologic: CBC (Hgb, WBC, Plt), INR Liver function: Alk Phos, AST/ALT, Bilirubin Glucose/lipid tolerance: Glucose, Triglycerides Iron status: Iron, TIBC, Ferritin Serum proteins: Albumin
Insulin coverage
DEXA
thank you
Thank you